Immuno-Oncology

Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

February 28, 2021

Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment.

Annual Review of Immunology
Xianwen RenZemin Zhang
February 28, 2021
Open Access

Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy.

Cancer Cell International
Jingkai LiuQuan Liao
February 28, 2021

Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy.

Clinical Lung Cancer
Monika F KeiserMehmet Altan
February 28, 2021

TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism.

Journal for Immunotherapy of Cancer
Stefania CanèBenoit J Van den Eynde
February 28, 2021

Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
Richard S P HuangDouglas I Lin
February 28, 2021
Review

Considering the potential for gene-based therapy in prostate cancer.

Nature Reviews. Urology
Justin R Gregg, Timothy C Thompson
February 28, 2021

The binding epitope of sintilimab on PD-1 revealed by AbMap.

Acta Biochimica Et Biophysica Sinica
Mingliang MaSheng-Ce Tao
February 28, 2021

CRISPR Takes the Front Seat in CART-Cell Development.

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Claudia Manriquez-RomanSaad S Kenderian
February 28, 2021

TNF receptor-associated factor 3 restrains B cell receptor signaling in normal and malignant B cells.

The Journal of Biological Chemistry
Amy L WhillockGail A Bishop
February 28, 2021

Recombinant expression, purification and characterization of human soluble tumor necrosis factor receptor 2.

Protein Expression and Purification
An LiYiming Lu
February 27, 2021

Impact Of Cell-Free Plasma DNA In Metastatic And Non-Metastatic Prostate Cancer.

Current Molecular Medicine
Abdelraouf A AbonarShereen R Mohammed
February 27, 2021
Open Access

Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies.

BMC Cancer
Zhitao YingJun Zhu
February 27, 2021
Open Access

Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer.

Cancer Cell International
Li LiangTianshu Liu
February 27, 2021
Review
Open Access

mRNA vaccine for cancer immunotherapy.

Molecular Cancer
Lei MiaoLeaf Huang

Sign up to follow this feed and discover related papers.

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Biophysics of Adhesion

Alterations in cell adhesion can disrupt important cellular processes and lead to a variety of diseases, including cancer and arthritis. It is also essential for infectious organisms, such as bacteria or viruses, to cause diseases. Understanding the biophysics of cell adhesion can help understand these diseases. Discover the latest research on the biophysics of adhesion here.

© 2021 Meta ULC. All rights reserved
/feed-previews/immuno-oncology/81da74c3-3bbb-4b32-8039-085a2366985c